Organization: Institute for Biological Sciences

AbCelex licenses NRC platform technology

Toronto’s AbCelex Technologies Inc has signed an exclusive worldwide licensing agreement with the National Research Council‘s Institute for Biological Sciences to access its Pentabody platform technology. The privately-held firm will pay NRC an upfront payment, milestone payments and royalties based on future product sales for the technology, which will be used for all of its…

NRC and Berlin institute to conduct stroke research

The National Research Council’s Institute for Biological Sciences has entered a collaborative agreement with the Institute of Molecular Pharmacology in Berlin to establish a team of researchers to explore new ways of preventing and managing stroke. The research agreement will see researchers employ genomics and proteomics to follow changes of genes in a diseased state.…

NRC and Hemptown to create new enzyme technology

Vancouver’s Hemptown Clothing Inc has entered into an R&D collaboration with the National Research Council’s Institute for Biological Sciences to develop a patentable enzyme technology process for hemp production The objective of the collaboration is to develop a new fibre technology for introduction into the market within three years. Hemptown plans to use the technology…

Dow licenses NRC’s pathogen-fighting technology

Dow AgroSciences has obtained worldwide licensing rights from the National Research Council (NRC) to market technologies that reduce the risk of food-borne pathogens. The agreement gives the company exclusive rights to specific antibody technologies that are being developed under a 2001 collaborative agreement between Dow AgroSciences Canada and NRC’s Institute for Biological Sciences in Ottawa.…

Dow AgroSciences to market NRC technologies

Dow AgroSciences, Indianapolis IN, will market antibody technologies developed under a 2001 collaboration agreement between its Canadian subsidiary and the National Research Council’s Institute for Biological Sciences. The licence agreement will see the technologies used to reduce the risk of food-borne pathogens by attacking them at the source without the use of traditional antibiotics. FMI:…